24.08.2018 22:45:00

Global Hemodynamic Monitoring Systems Market to 2023

DUBLIN, Aug 24, 2018 /PRNewswire/ --

Research and Markets Logo. (PRNewsFoto/Research and Markets) (PRNewsfoto/Research and Markets)

The "Hemodynamic Monitoring Systems Market by Product (Disposables and Monitors), Type (Invasive, Minimally Invasive, and Non-invasive), End User (Hospitals, Clinics & Ambulatory Care Center, and Home Care Setting), and Region - Global Forecasts to 2023" report has been added to ResearchAndMarkets.com's offering. 

The global hemodynamic monitoring systems market is expected to reach USD 1,167.4 million by 2023 from USD 857.8 million in 2018, at a CAGR of 6.4% during the forecast period.

The growth of this market is primarily driven by factors such as the technological advancements in hemodynamic monitoring systems, increasing research into hemodynamic monitoring systems, influx of VC funding, and the rising prevalence of cardiovascular diseases & diabetes.

The hemodynamic monitoring systems market is segmented on the basis of product, type, end user, and region. By product, the market is segmented into two broad categories monitors and disposables. The monitors segment is expected to grow at the highest CAGR during the forecast period. This can be attributed to the increasing prevalence of CVDs, technological advancements in monitoring systems, and increasing funding by government authorities to improve patient-centered care, safety, and efficiency.

By type, the global hemodynamic monitoring systems market is segmented into invasive, minimally invasive, and noninvasive hemodynamic monitoring systems. The noninvasive hemodynamic monitoring systems segment is expected to grow at the highest CAGR during the forecast, The rising incidence of respiratory disorders, increasing geriatric population, fewer complications of noninvasive hemodynamic monitoring as compared to invasive methods, better portability, ease of use, and better precision are the major factors driving the growth of this market segment.

On the basis of end user, the global hemodynamic monitoring systems market is segmented into hospitals, clinics and ambulatory care centers (ACCs), and home care settings. In 2018, the hospitals segment is expected to account for the largest share of the global hemodynamic monitoring systems market. The large share of this segment can be attributed to the presence of big cath labs in hospitals, successful applications of hemodynamic monitoring systems in several procedures, increase in the prevalence of cardiovascular and other chronic diseases, and continuous technological advancements coupled with government funding.

Geographic segments in this report include North America, Europe, Asia Pacific, and RoW. Of these, the North American region is expected to account for the largest share of the market in 2018. In North America, the hemodynamic monitoring systems market is driven by rising geriatric population and the increasing prevalence of diabetes and hypertension. In the US, the availability of technologically advanced hemodynamic monitoring systems, a large base of major device manufacturers, and favorable reimbursement scenario are some of the key factors driving the market for hemodynamic monitoring systems. In Canada, the growth of the market is driven by the growing use of patient monitoring systems and the development of technologically advanced hemodynamic monitoring systems.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

4.1 Hemodynamic Monitoring Systems Market Overview
4.2 Asia Pacific: Hemodynamic Monitoring Systems Market, By Country and End User
4.3 Geographic Snapshot: Global Hemodynamic Monitoring Systems Market
4.4 Global Hemodynamic Monitoring Systems Market, By Type (2018 vs 2023)

5 Market Overview

5.1 Introduction
5.2 Market Dynamics
5.3 Drivers
5.3.1 Technological Advancements in Hemodynamic Monitoring Systems
5.3.1.1 Microelectromechanical Systems (MEMS)
5.3.1.2 Hypotension Prediction Index (HPI) Software
5.3.2 Increasing Research Into Hemodynamic Monitoring Systems
5.3.3 Influx of VC Funding
5.3.4 Rising Prevalence of Cardiovascular Diseases and Diabetes
5.3.5 Rising Geriatric Population and Growing Number of Surgeries
5.3.6 Awareness Initiatives By Industry Players
5.3.7 Government Focus on Critical Care Infrastructure and Services
5.4 Restraints
5.4.1 Risks Associated With Invasive Hemodynamic Monitoring
5.5 Opportunities
5.5.1 Emerging Markets
5.5.2 Growing Demand for Patient Monitoring Devices in Non-Hospital Settings
5.6 Challenges
5.6.1 Increasing Pricing Pressure on Market Players
5.6.2 Limited Patient Awareness Related to Disease Diagnosis
5.6.3 Dearth of Skilled Professionals

6 Hemodynamic Monitoring Systems Market, By Product

6.1 Introduction
6.2 Disposables
6.3 Monitors

7 Hemodynamic Monitoring Systems Market, By Type

7.1 Introduction
7.2 Invasive Hemodynamic Monitoring Systems
7.3 Minimally Invasive Hemodynamic Monitoring Systems
7.4 Noninvasive Hemodynamic Monitoring Systems

8 Hemodynamic Monitoring Systems Market, By End User

8.1 Introduction
8.2 Hospitals
8.3 Clinics and Ambulatory Care Centers
8.4 Home Care Settings

9 Hemodynamic Monitoring Systems Market, By Region

9.1 Introduction
9.2 North America
9.2.1 US
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 RoE
9.4 Asia Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 RoAPAC
9.5 RoW

10 Competitive Landscape

10.1 Introduction
10.2 Hemodynamic Monitoring Systems Market Share Analysis
10.2.1 Edwards Lifesciences Corporation
10.2.2 Pulsion Medical Systems Se
10.2.3 Lidco Group PLC
10.3 Hemodynamic Monitoring Systems Market Share Analysis, By Region
10.4 Competitive Scenario

11 Company Profiles

11.1 Edwards Lifesciences Corporation
11.2 Pulsion Medical Systems Se (Part of the Maquet Getinge Group)
11.3 Lidco Group
11.4 Deltex Medical Group PLC
11.5 ICU Medical
11.6 Cnsystems Medizintechnik GmbH
11.7 Caretaker Medical
11.8 Osypka Medical GmbH
11.9 Cheetah Medical
11.10 NI Medical
11.11 Uscom

For more information about this report visit https://www.researchandmarkets.com/research/v2cr7r/global?w=5

Media Contact:


Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

 



Cision View original content with multimedia:http://www.prnewswire.com/news-releases/global-hemodynamic-monitoring-systems-market-to-2023-300702082.html

SOURCE Research and Markets

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!